Skip to main content
SpringerLink
Log in

Progesterone Receptor Isoforms in Normal and Malignant Breast

  • Conference paper
  • First Online:
Progestins and the Mammary Gland

Part of the book series: Ernst Schering Foundation Symposium Proceedings ((SCHERING FOUND,volume 2007/1))

Abstract

Progesterone is an essential regulator of normal female reproductive function, yet recent studies on the use of progestins in hormone replacement therapy have clearly implicated progestins in breast cancer development, a disease initiated early in life at a time of frequent exposure to cycling ovarian hormones. The effects of progesterone are mediated by two distinct nuclear receptor proteins, PRA and PRB. In normal breast PRA and PRB are co-expressed at similar levels in luminal epithelial cells, suggesting that both proteins are required to mediate physiologically relevant progesterone signalling. However, early in breast carcinogenesis PRA:PRB expression is disrupted, resulting in frequent predominance of one isoform. Unbalanced expression of PRA and PRB results in altered hormonal response and aberrant targeting of genes that are not normally progestin-regulated, principally those involved in morphological changes and disruptions of the actin cytoskeleton, and in migration. Movement of PR into discrete nuclear domains, or foci, is a critical step in normal PR transcriptional activity that appears to be aberrant in cancers and likely related to alterations in nuclear morphology, gene expression and cell function associated with tumour cells. Given that exogenous progestins are consumed by millions of women worldwide in the form of hormone replacement therapy and oral contraceptives, it is vital to better understand the mechanisms of progesterone action in the breast.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anderson E (2002) The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res 4:197–201

    Article  PubMed  CAS  Google Scholar 

  • Arnett-Mansfield RL, DeFazio A, Mote PA, Clarke CL (2004) Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium. J Clin Endocrinol Metab 89:1429–1442

    Article  PubMed  CAS  Google Scholar 

  • Arnett-Mansfield RL, Graham JD, Hanson AR, Mote PA, Gompel A, Scurr LL, Gava N, de Fazio A, Clarke CL (2007) Focal subnuclear distribution of progesterone receptor is ligand dependent and associated with transcriptional activity. Mol Endocrinol 21:14–29

    Article  PubMed  CAS  Google Scholar 

  • Bain DL, Franden MA, McManaman JL, Takimoto GS, Horwitz KB (2001) The N-terminal region of human progesterone B-receptors: biophysical and biochemical comparison to A-receptors. J Biol Chem 276:23825–23831

    Article  PubMed  CAS  Google Scholar 

  • Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427

    Article  PubMed  CAS  Google Scholar 

  • Bocchinfuso WP, Korach KS (1998) Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2:323–334

    Article  PubMed  CAS  Google Scholar 

  • Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA (1998) A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA 95:5076–5081

    Article  PubMed  CAS  Google Scholar 

  • Brody JG, Rudel RA, Michels KB, Mousich KB, Bernstein L, Attfield KR, Gray S (2007) Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention? Cancer 109:2627–2634

    Article  PubMed  Google Scholar 

  • Clavel-Chapelon F, Gerber M (2002) Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat 72:107–115

    Article  PubMed  CAS  Google Scholar 

  • Conneely OM, Mulac-Jericevic B, Lydon JP, De Mayo FJ (2001) Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol Cell Endocrinol 179:97–103

    Article  PubMed  CAS  Google Scholar 

  • Dowsett M, Cuzick J, Wale C, Howell T, Houghton J, Baum M (2005) Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study. J Clin Oncol 23:7512–7517

    Article  PubMed  CAS  Google Scholar 

  • Garcia SB, Park HS, Novelli M, Wright NA (1999) Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol 187:61–81

    Article  PubMed  CAS  Google Scholar 

  • Germain P, Altucci L, Bourguet W, Rochette-Egly C, Gronemeyer H (2003) Nuclear receptor superfamily: principles of signalling. Pure Appl Chem 75:1619–1664

    Article  CAS  Google Scholar 

  • Giangrande PH, Kimbrel EA, Edwards DP, McDonnell DP (2000) The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 20:3102–3115

    Article  PubMed  CAS  Google Scholar 

  • Goepfert TM, McCarthy M, Kittrell FS, Stephens C, Ullrich RL, Brinkley BR, Medina D (2000) Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells. FASEB J 14:2221–2229

    Article  PubMed  CAS  Google Scholar 

  • Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WR (2002) Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res 62:4115–4122

    PubMed  CAS  Google Scholar 

  • Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM (2001) Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res 7:2410–2414

    PubMed  CAS  Google Scholar 

  • Graham JD, Clarke CL (1997) Physiological action of progesterone in target tissues. Endocr Rev 18:502–519

    Article  PubMed  CAS  Google Scholar 

  • Graham JD, Clarke CL (2002) Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res 4:187–190

    Article  PubMed  CAS  Google Scholar 

  • Graham JD, Yager ML, Hill HD, Byth K, O'Neill GM, Clarke CL (2005) Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells. Mol Endocrinol 19:2713–2735

    Article  PubMed  CAS  Google Scholar 

  • Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL (1995) Characterisation of progesterone receptor A and B protein expression in human breast cancer. Cancer Res 55:5063–5068

    PubMed  CAS  Google Scholar 

  • Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30–37

    Article  PubMed  CAS  Google Scholar 

  • Hopp TA, Weiss HL, Hilsenbeck SG, Cui Y, Allred DC, Horwitz KB, Fuqua SAW (2004) Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates. Clin Cancer Res 10:2751–2760

    Article  PubMed  CAS  Google Scholar 

  • Howard BA, Gusterson BA (2000) Human breast development. J Mammary Gland Biol Neoplasia 5:119–137

    Article  PubMed  CAS  Google Scholar 

  • Htun H, Holth LT, Walker D, Davie JR, Hager GL (1999) Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell 10:471–486

    PubMed  CAS  Google Scholar 

  • Huse B, Verca SB, Matthey P, Rusconi S (1998) Definition of a negative modulation domain in the human progesterone receptor. Mol Endocrinol 12:1334–1342

    Article  PubMed  CAS  Google Scholar 

  • Isaksson E, Wang H, Sahlin L, von Schoultz B, Cline JM, von Schoultz E (2003) Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques. Breast Cancer Res Treat 79:233–239

    Article  PubMed  CAS  Google Scholar 

  • Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603–1614

    PubMed  CAS  Google Scholar 

  • Kawate H, Wu Y, Ohnaka K, Tao RH, Nakamura K, Okabe T, Yanase T, Nawata H, Takayanagi R (2005) Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients. J Clin Endocrinol Metab 90:6162–6169

    Article  PubMed  CAS  Google Scholar 

  • Larson PS, de las Morenas A, Bennett SR, Cupples LA, Rosenberg CL (2002) Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. Am J Pathol 161:283–290

    Article  PubMed  Google Scholar 

  • Larson PS, de las Morenas A, Cupples LA, Huang K, Rosenberg CL (1998) Genetically abnormal clones in histologically normal breast tissue. Am J Pathol 152:1591–1598

    PubMed  CAS  Google Scholar 

  • Lee SA, Ross RK, Pike MC (2005) An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk. Br J Cancer 92:2049–2058

    Article  PubMed  CAS  Google Scholar 

  • Longacre TA, Bartow SA (1986) A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10:382–393

    Article  PubMed  CAS  Google Scholar 

  • Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW (1999) Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 59:4276–4284

    PubMed  CAS  Google Scholar 

  • McDonnell DP, Goldman ME (1994) RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. J Biol Chem 269:11945–11949

    PubMed  CAS  Google Scholar 

  • McGowan EM, Saad S, Bendall LJ, Bradstock KF, Clarke CL (2004) Effect of progesterone receptor A predominance on breast cancer cell migration into bone marrow fibroblasts. Breast Cancer Res Treat 83:211–220

    Article  PubMed  CAS  Google Scholar 

  • McGowan EM, Weinberger RP, Graham JD, Hill HD, Hughes JA, O'Neill GM, Clarke CL (2003) Cytoskeletal responsiveness to progestins is dependent on progesterone receptor A levels. J Mol Endocrinol 31:241–253

    Article  PubMed  CAS  Google Scholar 

  • McKenna NJ, O'Malley BW (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465–474

    Article  PubMed  CAS  Google Scholar 

  • McNally JG, Muller WG, Walker D, Wolford R, Hager GL (2000) The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287:1262–1265

    Article  PubMed  CAS  Google Scholar 

  • McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study I (2005) Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst 97:1366–1376

    Article  PubMed  CAS  Google Scholar 

  • Mote PA, Balleine RL, McGowan EM, Clarke CL (1999) Co-localization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 84:2963–2971

    Article  PubMed  CAS  Google Scholar 

  • Mote PA, Balleine RL, McGowan EM, Clarke CL (2000) Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum Reprod 15:48–56

    PubMed  CAS  Google Scholar 

  • Mote PA, Bartow S, Tran N, Clarke CL (2002) Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72:163–172

    Article  PubMed  CAS  Google Scholar 

  • Mote PA, Leary JA, Avery KA, Sandelin K, Chenevix-Trench G, Kirk JA, Clarke CL (2004) Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. Genes Chromosomes Cancer 39:236–248

    Article  PubMed  CAS  Google Scholar 

  • Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM (2000) Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289:1751–1754

    Article  PubMed  CAS  Google Scholar 

  • Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM (2003) Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 100:9744–9749

    Article  PubMed  CAS  Google Scholar 

  • Nishi M, Ogawa H, Ito T, Matsuda KI, Kawata M (2001) Dynamic changes in subcellular localization of mineralocorticoid receptor in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent protein spectral variants. Mol Endocrinol 15:1077–1092

    Article  PubMed  CAS  Google Scholar 

  • Osborne CK, Schiff R, Arpino G, Lee AS, Hilsenbeck VG (2005) Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy. Breast 14:458–465

    Article  PubMed  Google Scholar 

  • Park CC, Henshall-Powell RL, Erickson AC, Talhouk R, Parvin B, Bissell MJ, Barcellos-Hoff MH (2003) Ionizing radiation induces heritable disruption of epithelial cell interactions. Proc Natl Acad Sci USA 100:10728–10733

    Article  PubMed  CAS  Google Scholar 

  • Prufer K, Racz A, Lin GC, Barsony J (2000) Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J Biol Chem 275:41114–41123

    Article  PubMed  CAS  Google Scholar 

  • Racz A, Barsony J (1999) Hormone-dependent translocation of vitamin D receptors is linked to transactivation. J Biol Chem 274:19352–19360

    Article  PubMed  CAS  Google Scholar 

  • Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB (2002) Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209–5218

    Article  PubMed  CAS  Google Scholar 

  • Rossouw J, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288:321–333

    Article  PubMed  CAS  Google Scholar 

  • Santen RJ (2003) Risk of breast cancer with progestins: critical assessment of current data. Steroids 68:953–964

    Article  PubMed  CAS  Google Scholar 

  • Santen RJ, Pinkerton J, McCartney C, Petroni GR (2001) Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy. J Clin Endocrinol Metab 86:16–23

    Article  PubMed  CAS  Google Scholar 

  • Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB (1994) A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8:1347–1360

    Article  PubMed  CAS  Google Scholar 

  • Schneider W, Ramachandran C, Satyaswaroop PG, Shyamala G (1991) Murine progesterone receptor exists predominantly as the 83-kilodalton ‘A’ form. J Steroid Biochem Mol Biol 38:285–291

    Article  PubMed  CAS  Google Scholar 

  • Shyamala G, Yang X, Cardiff RD, Dale E (2000) Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci USA 97:3044–3049

    Article  PubMed  CAS  Google Scholar 

  • Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E (1998) Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA 95:696–701

    Article  PubMed  CAS  Google Scholar 

  • Smalley M, Ashworth A (2003) Stem cells and breast cancer: a field in transit. Nat Rev Cancer 3:832–844

    Article  PubMed  CAS  Google Scholar 

  • Soderqvist G, Isaksson E, von Schoultz B, Carlstrom K, Tani E, Skoog L (1997) Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 176:123–128

    Article  PubMed  CAS  Google Scholar 

  • Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874

    Article  PubMed  CAS  Google Scholar 

  • Tomura A, Goto K, Morinaga H, Nomura M, Okabe T, Yanase T, Takayanagi R, Nawata H (2001) The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J Biol Chem 276:28395–28401

    Article  PubMed  CAS  Google Scholar 

  • Topper YJ, Freeman CS (1980) Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60:1049–1106

    PubMed  CAS  Google Scholar 

  • Tsai MJ, O'Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451–486

    Article  PubMed  CAS  Google Scholar 

  • Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB (1993) Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol Endocrinol 7:1256–1265

    Article  PubMed  CAS  Google Scholar 

  • Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP (1993) Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7:1244–1255

    Article  PubMed  CAS  Google Scholar 

  • Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182

    Article  PubMed  CAS  Google Scholar 

  • Wen DX, Xu YF, Mais DE, Goldman ME, McDonnell DP (1994) The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14:8356–8364

    PubMed  CAS  Google Scholar 

  • Wiehle RD, Helftenbein G, Land H, Neumann K, Beato M (1990) Establishment of rat endometrial cell lines by retroviral mediated transfer of immortalizing and transforming oncogenes. Oncogene 5:787–794

    PubMed  CAS  Google Scholar 

  • Yue W, Wang JP, Li Y, Bocchinfuso WP, Korach KS, Devanesan PD, Rogan E, Cavalieri E, Santen RJ (2005) Tamoxifen versus aromatase inhibitors for breast cancer prevention. Clin Cancer Res 11:925s–930s

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. P. A. Mote, J. D. Graham & C. L. Clarke

    Present address: Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Darcy Rd, 2145, Westmead, NSW, Australia

Authors and Affiliations

    Authors
    1. P. A. Mote
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. J. D. Graham
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. C. L. Clarke
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to C. L. Clarke .

    Editor information

    O. Conneely C. Otto

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2008 Springer-Verlag

    About this paper

    Cite this paper

    Mote, P.A., Graham, J.D., Clarke, C.L. (2008). Progesterone Receptor Isoforms in Normal and Malignant Breast. In: Conneely, O., Otto, C. (eds) Progestins and the Mammary Gland. Ernst Schering Foundation Symposium Proceedings, vol 2007/1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/2789_2008_076

    Download citation

    • DOI: https://doi.org/10.1007/2789_2008_076

    • Published:

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-540-73492-5

    • Online ISBN: 978-3-540-73493-2

    • eBook Packages: MedicineMedicine (R0)

    Publish with us

    Policies and ethics

    Search

    Navigation